Last Update Time:
13-Mar-2025 15:14:36
ISIN:
INE0LA901015
Sector:
Healthcare
Symbol:
JFLLIFE
Jfl Life Sciences Limited
₹0.00
₹0.00
(0.00%)
▲
Prev. Close
₹N/A
Open
₹0.00
Close
₹19.45
Range
₹0.00 - ₹0.00
High
₹0.00
Low
₹0.00
Ind. Close
₹0.00
VWAP
₹0.00
The current stock price of Jfl Life Sciences Limited is ₹0.00, with a target price range between ₹0.00 and ₹0.00. The stock has experienced a price change of ₹0.00 (0.00%), reflecting recent market volatility.
Today's opening price was ₹0.00, while the previous close stood at ₹0.00.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Jfl Life Sciences Limited Price Chart
Jfl Life Sciences Limited Pre Open Market Overview: N/A
Key Metrics:
- IEP (Indicative Equilibrium Price): 0
- Previous Close Price: 0
- Change: 0.00%
- Total Traded Volume: 0
- Total Buy Quantity: 0
- Total Sell Quantity: 0
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 0.00 | 0.00 | 0.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 0
Total Sell Quantity: 0
Shareholding Patterns of Jfl Life Sciences Limited
Key Trade Statistics of Jfl Life Sciences Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | N/A |
| Traded Value (₹ Cr.) | N/A |
| Total Market Cap (₹ Cr.) | 64.18 |
| Free Float Market Cap (₹ Cr.) | N/A |
| Impact cost | N/A |
| Quantity Traded | N/A |
| Deliverable Quantity | N/A |
| % of Quantity to Traded | N/A |
| Security VaR | N/A |
| Index VaR | N/A |
| VaR Margin | N/A |
| Extreme Loss Rate | N/A |
| Adhoc Margin | N/A |
| Applicable Margin Rate | N/A |
| Face Value | 10 |
Key Price Statistics of Jfl Life Sciences Limited
The 52-week high for Jfl Life Sciences Limited was ₹37.15, recorded on 25-Nov-2024. On the other hand, the 52-week low stands at ₹12.02, with the lowest value recorded on 14-Mar-2024.
The upper band for trading is ₹19.80, and the lower band is ₹19.10. The price band is 2%.
The stock's daily volatility stands at N/A, while the annualized volatility is N/A. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (25-Nov-2024) | 37.15 |
| 52 Week Low (14-Mar-2024) | 12.02 |
| Upper Band | 19.80 |
| Lower Band | 19.10 |
| Price Band (%) | 2 |
| Daily Volatility | - |
| Annualised Volatility | - |
| Tick Size | 0.05 |
Key Securities Statistics of Jfl Life Sciences Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 08-Sep-2022 |
| Adjusted P/E | NA |
| Symbol P/E | NA |
| Index | NIFTY SME EMERGE |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Jfl Life Sciences Limited
| Title | Details |
|---|---|
| Board Status | SME |
| Trading Segment | Call Auction |
| Session No. | 1 |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Jfl Life Sciences Limited
| Subject | Date |
|---|---|
| Action(s) initiated or orders passed | 28-Feb-2025 |
| General Updates | 28-Feb-2025 |
| Action(s) taken or orders passed | 11-Feb-2025 |
| Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 24-Jan-2025 |
| Cessation | 24-Jan-2025 |
| Updates | 07-Jan-2025 |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 06-Jan-2025 |
| Updates | 06-Jan-2025 |
Corporate Actions of Jfl Life Sciences Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | BONUS 2:1 | 24-Sep-2024 |
| 10 | DIVIDEND - RE 0.25 PER SHARE | 13-Sep-2024 |
Board Meetings of Jfl Life Sciences Limited
Financial Results of Jfl Life Sciences Limited
Company Directory of Jfl Life Sciences Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| - | Registered Address | 309, Satyam Mall, Opp. Saman Complex, Nr. Vishweshwar Mahadev Mandir, Settelite, AHMEDABAD - 380015 AHMEDABAD |
AHMEDABAD |
| - | Transfer Agent | Selenium Tower-B, Plot 31 & 32, Gachibowli, Financial District, Nanakramguda, Serilingampally, HYDERABAD - 500032 HYDERABAD |
HYDERABAD |
Insider Trading of Jfl Life Sciences Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type | ||
|---|---|---|---|---|---|
| No insider trading information available | |||||
Annual Reports of Jfl Life Sciences Limited
| Company | From Year | To Year | Att. |
|---|---|---|---|
| Jfl Life Sciences Limited | 2023 | 2024 | |
| Jfl Life Sciences Limited | 2022 | 2023 |
Investor Complaints of Jfl Life Sciences Limited
Event Calendar of Jfl Life Sciences Limited
| Purpose | Details |
|---|---|
| Board Meeting Intimation | JFL LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Half Yearly ended September 2024 . |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| JFL LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 31-Aug-2024 to consider Other business. | Board Meeting Intimation |
| Other business matters | To consider other business matters as follows: 1. To consider and approve the Director s Report along with the annexures for the year ending 31st March, 2024.2. To consider and approve the Notice of 14th Annual General Meeting for the year ending 31st March, 2024.3. To consider appointment of M/s. Prachi Prajapati & Associates., Practising Company Secretaries as Scrutinizers for e-voting process to be conducted at the ensuing 14th Annual General Meeting of the company.4. To consider the appointment of M/s Prachi Prajapati & Associates, Practising Company Secretaries as Secretarial Auditor of the Company for FY 2024-25.5. To consider the appointment of P H P & Associates, Chartered Accountants as Internal Auditor of the Company for FY 2024-25.6. Any other business with the permission of the chair and the majority of the directors present at the meeting. |
| JFL LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 02-Aug-2024 to consider and approve Increase in authorised capital/Bonus/Fund raising/Dividend. | Board Meeting Intimation |
| Dividend/Bonus/Fund Raising/Other business matters | To consider dividend, bonus, Fund Raising and other business matters |
| JFL LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 27-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Other business. | Board Meeting Intimation |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2024 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| JFL LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 08-Nov-2023 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2023 and Other business. | Board Meeting Intimation |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| JFL LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 01-Sep-2023 to consider Other business. | Board Meeting Intimation |
| Other business matters | To consider other business matters as specified in the notice |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2023 and other business matters |
| Other business matters | To consider other business matters as disclosed in the notice for calling Independent Directors Meeting. |
| Financial results/Other business matters | Jfl Life Sciences Limited has informed the Exchange about Board Meeting to be held on 12-Nov-2022 to consider financial statements for the period ended September 2022 and Other business matters as follows:1 To consider appointment of Malvika Jagani (Mem. No.: A46722), as Company Secretary & Compliance Officer of the Company.2. To consider appointment of Internal Auditor for the company for financial year 2022-2023.3. To consider appointment of Secretarial Auditor for the Company for financial year 2022-2023. |
Share Transfers of Jfl Life Sciences Limited
| Company | Period | Reg.7 | Reg.40 |
|---|---|---|---|
| Jfl Life Sciences Limited | 31-MAR-2024 | ||
| Jfl Life Sciences Limited | 31-MAR-2023 |
Voting Results of Jfl Life Sciences Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 23-SEP-2024 | AGM | TO RECEIVE, CONSIDER AND ADOPT THE AUDITED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31, 2024 ALONG WITH THE DIRECTORS' REPORT AND AUDITOR'S REPORT THEREON |
| 23-SEP-2024 | AGM | TO ISSUE BONUS SHARES BY WAY OF CAPITALISATION OF RESERVES |
| 23-SEP-2024 | AGM | TO INCREASE THE AUTHORISED SHARE CAPITAL OF THE COMPANY AND CONSEQUENTIAL AMENDMENT IN THE MEMORANDUM OF ASSOCIATION OF THE COMPANY |
| 23-SEP-2024 | AGM | TO APPOINT A DIRECTOR IN PLACE OF SHRI MANISHKUMAR JASVANTLAL PATEL (DIN: 09499355), NON-EXECUTIVE DIRECTOR, WHO RETIRES BY ROTATION AS DIRECTOR AND BEING ELIGIBLE, OFFERS HIMSELF FOR RE-APPOINTMENT. |
| 23-SEP-2024 | AGM | TO DECLARE THE DIVIDEND ON EQUITY SHARES FOR THE FINANCIAL YEAR ENDED MARCH 31, 2024 |
| 27-SEP-2023 | AGM | To receive, consider and adopt the Financial Statements of the company which includes Audited Balance Sheet as at March 31st, 2023, the Statement of Profit and Loss Account, Cash Flow Statement & Notes forming part of the Financial Statements for the year ended on that date together with the Auditorￂs Report thereon and Report of the Board of Directors. |
| 27-SEP-2023 | AGM | To appoint Mr. Manishkumar Jasvantal Patel (DIN: 09499355), who retire by rotation and being eligible, offers himself for re-appointment as Director. |
FAQs on Jfl Life Sciences Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.